(Press-News.org) A new disinfectant, Akwaton, that works at extremely low concentrations could be used in healthcare settings to help control persistent hospital-acquired infections such as Clostridium difficile. The study is reported online in the Journal of Medical Microbiology.
Researchers from the Université de Saint-Boniface in Winnipeg, Canada tested the new compound, Akwaton, against bacterial spores that attach to surfaces and are difficult to destroy. Previous work by the group has shown Akwaton is also effective at low concentrations against strains of Meticillin-resistant Staphylococcus aureus and Escherichia coli.
Spore-forming bacteria include C. difficile - a common bacterium found in healthcare settings whose spores can survive on surfaces for long periods of time. Spores are heat-tolerant and can survive a number of years in a dehydrated state before they are reactivated. Most chemical disinfectants control or prevent spore growth rather than irreversibly destroying them.
The present study showed that Akwaton was able to destroy Bacillus subtilis bacterial spores, suspended in water and attached to stainless steel or glass surfaces, at concentrations well below 1% after just 90 seconds' treatment. It was equally as effective at more dilute concentrations (below 0.1%) if left to act for longer periods.
Lead researcher Dr Mathias Oulé, explained the advantages over other chemical compounds currently used against bacterial spores. "Most disinfectants have to be applied at much higher concentrations – typically between 4-10% - to properly get rid of bacterial spores. Unfortunately such high levels of these compounds may also be harmful to humans and other animals. Akwaton is non-corrosive, non-irritable, odourless and is effective at very low concentrations," he said.
"Bacterial spores demonstrate a remarkable resistance to physical and chemical agents as well as ordinary antiseptics. On top of this micro-organisms are becoming increasingly resistant to disinfectants as well as antibiotics. Our latest study shows Akwaton is effective at destroying these spores as well as bacteria that are known problems in healthcare environments"
Akwaton is fast-acting and non-toxic for humans at low concentrations. Other studies have shown that the compound is also environmentally safe. "All these properties make it an ideal disinfectant for hospitals and laboratories. It may also have great value in the food industry to tackle spore-forming food pathogens such as Bacillus cereus and Clostridium perfringens," explained Dr Oulé.
###
Disclaimer: The Society for General for Microbiology is reporting on a scientific study published in its own publication, Journal of Medical Microbiology. The Society does not endorse or promote use of Akwaton and holds no relationship with its commercial suppliers or distributers.
New non-toxic disinfectant could tackle hospital infections
2012-08-08
ELSE PRESS RELEASES FROM THIS DATE:
Innovation crisis in drug research is a myth, warn experts
2012-08-08
They say the real crisis stems from current incentives that reward companies for developing large numbers of new drugs with few clinical advantages over existing ones.
Since the early 2000s, numerous articles and reports have claimed that the pipeline for new drugs will soon run dry, write Donald Light from the University of Medicine and Dentistry of New Jersey and Joel Lexchin from York University in Toronto. Yet data indicate that the number of new drugs licensed remains at the long term average range of 15-25 a year.
The authors argue that telling "innovation crisis" ...
Families should not be allowed to veto dead relatives' organ donation wishes
2012-08-08
It has recently been suggested that patients should be kept alive using elective ventilation to facilitate the harvesting of organs for donation. But David Shaw, Honorary Lecturer at the University of Aberdeen believes there is a much simpler way to increase the number of donated organs – by ensuring that doctors respect the wishes of the deceased and over-rule any veto.
Veto by the family is the main impediment to an increase in organ donation, with at least 10% of families refusing to donate. Yet Shaw points out that families have no legal grounds for over-riding the ...
Balance and strength training can prevent falls in older people
2012-08-08
Balance and strength training is known to reduce falls in older adults. However, less than 10% of older people routinely engage in strength training and it is likely that this is much lower for activities that challenge balance.
It has been suggested that integrating exercise into everyday activities may help people stick to it, but this approach has never been investigated in frail older people at risk of falls.
So a team of researchers at the University of Sydney designed and tested the Lifestyle integrated Functional Exercise (LiFE) programme, which involves embedding ...
Study finds a new pathway for invasive species – science teachers
2012-08-08
CORVALLIS, Ore. – A survey of teachers from the United States and Canada found that one out of four educators who used live animals as part of their science curriculum released the organisms into the wild after they were done using them in the classroom.
Yet only 10 percent of those teachers participated in a planned release program, increasing the likelihood that the well-intentioned practice of using live organisms as a teaching tool may be contributing to invasive species problems.
The study was presented today (Aug. 7) in Portland at the national meeting of the ...
Plain packaging of cigarettes encourages young smokers to heed health warnings
2012-08-08
New research published online in the scientific journal Addiction shows that plain packaging (requiring cigarettes to be packaged in standard packages without attractive designs and imagery) may help to draw the attention of some adolescent smokers to the health warnings on the package. If so, this may in turn deter young smokers from continuing to smoke.
Researchers asked eighty-seven teenage secondary school (high school) students from the city of Bristol, UK, to look at twenty images of cigarette packs on a computer screen for ten seconds each while a device tracked ...
Thinner diabetics face higher death rate
2012-08-08
CHICAGO --- American adults of a normal weight with new-onset diabetes die at a higher rate than overweight/obese adults with the same disease, according to a new Northwestern Medicine study.
The study, to be published in the Aug. 7 issue of JAMA, found that normal-weight participants experienced both significantly higher total and non-cardiovascular mortality than overweight/obese participants.
Normal-weight adults with type 2 diabetes have been understudied because those who typically develop the disease are overweight or obese. In this study about 10 percent of those ...
Coach could be key in helping stroke patients
2012-08-08
WINSTON-SALEM, N.C. – August 6, 2012 – When a stroke patient is discharged from the hospital, they often must cope with a new disability or lack of function, so changes in their medications or a new dosing prescription can be particularly confusing. This can lead the patient to overmedicate, take the wrong medication or skip medications entirely and can result in being readmitted to the hospital.
But a pilot study that is looking at a new discharge strategy and being led by researchers at Wake Forest Baptist Medical Center, indicates that phone calls and conversations ...
Using millions of years of cell evolution in the fight against cancer
2012-08-08
As the medical community continues to make positive strides in personalized cancer therapy, scientists know some dead ends are unavoidable. Drugs that target specific genes in cancerous cells are effective, but not all proteins are targetable. In fact, it has been estimated that as few as 10 to 15 percent of human proteins are potentially targetable by drugs. For this reason, Georgia Tech researchers are focusing on ways to fight cancer by attacking defective genes before they are able to make proteins.
Professor John McDonald is studying micro RNAs (miRNAs), a class ...
UCF nanoparticle discovery opens door for pharmaceuticals
2012-08-08
What a University of Central Florida student thought was a failed experiment has led to a serendipitous discovery hailed by some scientists as a potential game changer for the mass production of nanoparticles.
Soroush Shabahang, a graduate student in CREOL (The College of Optics & Photonics), made the finding that could ultimately change the way pharmaceuticals are produced and delivered.
The discovery was based on using heat to break up long, thin fibers into tiny, proportionally sized seeds, which have the capability to hold multiple types of materials locked in ...
New drug successfully halts fibrosis in animal model of liver disease
2012-08-08
A study published in the online journal Hepatology reports a potential new NADPH oxidase (NOX) inhibitor therapy for liver fibrosis, a scarring process associated with chronic liver disease that can lead to loss of liver function.
"While numerous studies have now demonstrated that advanced liver fibrosis in patients and in experimental rodent models is reversible, there is currently no effective therapy for patients," said principal investigator David A. Brenner, MD, vice chancellor for Health Sciences and dean of the School of Medicine at the University of California, ...